X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS VENUS REMEDIES DR. DATSONS LABS/
VENUS REMEDIES
 
P/E (TTM) x -10.9 -8.9 - View Chart
P/BV x 0.2 0.1 116.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   VENUS REMEDIES
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
VENUS REMEDIES
Mar-17
DR. DATSONS LABS/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs126143 88.0%   
Low Rs3165 47.5%   
Sales per share (Unadj.) Rs133.0324.2 41.0%  
Earnings per share (Unadj.) Rs0.26.4 2.4%  
Cash flow per share (Unadj.) Rs6.640.6 16.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.8366.0 35.2%  
Shares outstanding (eoy) m31.6612.34 256.6%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.3 183.6%   
Avg P/E ratio x516.116.2 3,184.2%  
P/CF ratio (eoy) x11.82.6 462.5%  
Price / Book Value ratio x0.60.3 214.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4771,282 193.2%   
No. of employees `000NA0.9 0.0%   
Total wages/salary Rs m56251 22.3%   
Avg. sales/employee Rs ThNM4,430.1-  
Avg. wages/employee Rs ThNM278.0-  
Avg. net profit/employee Rs ThNM87.6-  
INCOME DATA
Net Sales Rs m4,2114,000 105.3%  
Other income Rs m7923 346.7%   
Total revenues Rs m4,2894,023 106.6%   
Gross profit Rs m569785 72.5%  
Depreciation Rs m204422 48.5%   
Interest Rs m430344 125.2%   
Profit before tax Rs m1342 30.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-37 -16.5%   
Profit after tax Rs m579 6.1%  
Gross profit margin %13.519.6 68.8%  
Effective tax rate %48.0-87.9 -54.7%   
Net profit margin %0.12.0 5.8%  
BALANCE SHEET DATA
Current assets Rs m6,8522,606 262.9%   
Current liabilities Rs m6,7111,980 338.9%   
Net working cap to sales %3.315.6 21.4%  
Current ratio x1.01.3 77.6%  
Inventory Days Days161128 125.4%  
Debtors Days Days31843 738.1%  
Net fixed assets Rs m3,6735,353 68.6%   
Share capital Rs m317123 256.6%   
"Free" reserves Rs m3,7614,393 85.6%   
Net worth Rs m4,0784,516 90.3%   
Long term debt Rs m1,6711,618 103.3%   
Total assets Rs m12,6338,291 152.4%  
Interest coverage x1.01.1 91.7%   
Debt to equity ratio x0.40.4 114.4%  
Sales to assets ratio x0.30.5 69.1%   
Return on assets %3.45.1 67.5%  
Return on equity %0.11.8 6.7%  
Return on capital %7.76.3 122.0%  
Exports to sales %22.90-   
Imports to sales %14.318.4 77.7%   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602736 81.7%   
Fx inflow Rs m9640-   
Fx outflow Rs m607736 82.5%   
Net fx Rs m357-736 -48.5%   
CASH FLOW
From Operations Rs m1,345997 134.9%  
From Investments Rs m-2,256-461 489.0%  
From Financial Activity Rs m-1,200-571 210.1%  
Net Cashflow Rs m-2,111-35 6,013.4%  

Share Holding

Indian Promoters % 4.5 32.9 13.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 1.4 0.6 232.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 66.4 141.7%  
Shareholders   20,807 20,121 103.4%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   PIRAMAL ENTERPRISES  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  NOVARTIS  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

VENUS REMEDIES Announces Quarterly Results (4QFY18); Net Profit Down 307.2%

Jun 12, 2018 | Updated on Jun 12, 2018

For the quarter ended March 2018, VENUS REMEDIES has posted a net profit of Rs 94 m (down 307.2% YoY). Sales on the other hand came in at Rs 932 m (up 16.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS